Clin Nephrol
-
Randomized Controlled Trial Multicenter Study
Efficacy and safety of lanthanum carbonate in pre-dialysis CKD patients with hyperphosphatemia: a randomized trial.
Lanthanum carbonate (LC), an effective non-calcium phosphate binder is widely used to manage hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. Recently, the additional indication for control of hyperphosphatemia in CKD patients not on dialysis has been approved. ⋯ This study demonstrated the effectiveness of LC to control hyperphosphatemia in pre-dialysis CKD patients.